L&C Bio Co Ltd
KOSDAQ:290650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ondas Holdings Inc
NASDAQ:ONDS
|
US |
L&C Bio Co Ltd
Tax Provision
L&C Bio Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
L&C Bio Co Ltd
KOSDAQ:290650
|
Tax Provision
₩6.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Tax Provision
-₩122.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-40%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Tax Provision
₩29.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Tax Provision
₩32.2m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Tax Provision
-₩17.6B
|
CAGR 3-Years
-446%
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Tax Provision
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
L&C Bio Co Ltd
Glance View
L&C BIO Co., Ltd. develops soft tissue, allografts, and medical devices. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-11-01. The firm mainly manufactures and sells human tissue transplant materials used for tissue repair and filler. The firm also produces and sells human tissue-based medical devices and Cosmeceuticals. Its products are used in vascular surgeries, plastic surgeries, general surgeries and others.
See Also
What is L&C Bio Co Ltd's Tax Provision?
Tax Provision
6.2B
KRW
Based on the financial report for Sep 30, 2025, L&C Bio Co Ltd's Tax Provision amounts to 6.2B KRW.
What is L&C Bio Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 1Y
5 834%
Over the last year, the Tax Provision growth was 5 834%.
